文献速递炎症性肠病

肥胖对炎症性肠病疾病活动度和患者报告结局测量信息系统(PROMIS)的影响

Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

在IBD Partners互联网队列中开展横断面和纵向研究,纳入7296例成人IBD患者(4748例CD,19.5%肥胖;2548例UC且结肠完整,20.3%肥胖)。肥胖呈剂量依赖性与CD和UC持续疾病活动或复发风险独立相关,并与CD和UC患者基线焦虑、抑郁、疲劳、疼痛及社交功能评分较差独立相关,纵向评估中与CD患者抑郁、疲劳、疼痛和社交功能恶化相关。

要点

  • 肥胖呈剂量依赖性与CD和UC持续疾病活动或复发风险独立相关。
  • CD中II或III级肥胖 vs 正常BMI:aOR 1.86(95%CI 1.30-2.68)。
  • UC中肥胖 vs 正常BMI:aOR 2.97(95%CI 1.75-5.17)。

核心结论

  • 基线肥胖与IBD患者疾病活动度恶化及PROMIS测量指标变差独立相关。

研究设计与样本

  • 在IBD Partners(基于互联网的队列,>15000例CD和UC患者)中开展横断面和纵向研究。
  • 纳入有BMI记录的成人IBD患者,随访至少6个月,排除BMI<18.5 kg/m²者。
  • 共纳入7296例IBD患者:4748例CD(19.5%肥胖),2548例UC且结肠完整(20.3%肥胖)。
  • 采用多变量logistic回归评估WHO肥胖分级对临床复发或持续疾病活动风险的独立效应,采用线性回归评估对PROMIS指标的效应。

主要发现

  • CD中II或III级肥胖 vs 正常BMI:调整OR 1.86(95%CI 1.30-2.68)。
  • UC中肥胖 vs 正常BMI:调整OR 2.97(95%CI 1.75-5.17)。
  • CD和UC患者基线时肥胖与更高的焦虑、抑郁、疲劳、疼痛及较差的社交功能评分独立相关。
  • 纵向评估中,CD患者肥胖与抑郁、疲劳、疼痛和社交功能恶化相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We conducted a cohort study on the impact of obesity on disease activity and Patient-Reported Outcomes Measurement Information System (PROMIS) measures in the inflammatory bowel disease (IBD) Partners cohort. METHODS: We performed a cross-sectional and longitudinal study within IBD Partners, an internet-based cohort of >15,000 patients living with Crohn's disease (CD) and ulcerative colitis (UC). We included adult patients with IBD, with recorded body mass index (BMI), with at least 6 months of follow-up, excluding patients with BMI < 18.5 kg/m. We evaluated the independent effect of World Health Organization classes of obesity on risk of clinical relapse or persistent disease activity (using validated disease activity indexes) and PROMIS measures, using multivariate logistic regression and linear regression, respectively. RESULTS: We included 7,296 patients with IBD (4,748 patients with CD, 19.5% obese; 2,548 patients with UC with intact colon, 20.3% obese). Obesity was independently, and in a dose-dependent fashion, associated with an increased risk of persistent disease activity or relapse in both patients with CD (class II or III obesity vs normal BMI: adjusted odds ratio, 1.86; 95% confidence interval, 1.30-2.68) and UC (adjusted odds ratio, 2.97; 95% confidence interval, 1.75-5.17). Obesity was also independently associated with higher anxiety, depression, fatigue, pain, and inferior social function scores in patients with CD and UC at baseline and with worsening depression, fatigue, pain, and social function in patients with CD on longitudinal assessment. DISCUSSION: Obesity at baseline is independently associated with worsening disease activity and PROMIS measures in patients with IBD.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Jain A, Nguyen NH, Proudfoot JA, et al. Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases. Am J Gastroenterol. 2019. PMID: 30865012. doi:10.14309/ajg.0000000000000197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。